# Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

> **NCT05917522** · PHASE2 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 800 (estimated)

## Conditions studied

- Kidney Transplant

## Interventions

- **BIOLOGICAL:** Abatacept
- **PROCEDURE:** Standard of Care at US Transplant Centers

## Key facts

- **NCT ID:** NCT05917522
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-07
- **Primary completion:** 2027-07
- **Final completion:** 2029-07
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05917522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05917522, "Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05917522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*